Kajima Corp provides civil engineering and project management for multiple industries... Show more
KAJMY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 29, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 55 instances where the indicator turned negative. In of the 55 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on January 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KAJMY as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KAJMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
KAJMY broke above its upper Bollinger Band on January 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KAJMY advanced for three days, in of 111 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 212 cases where KAJMY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KAJMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.210) is normal, around the industry mean (9.528). P/E Ratio (17.208) is within average values for comparable stocks, (113.191). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.069). Dividend Yield (0.019) settles around the average of (0.028) among similar stocks. P/S Ratio (0.974) is also within normal values, averaging (2.381).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry EngineeringConstruction
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VRAI | 24.96 | 0.34 | +1.37% |
| Virtus Real Asset Income ETF | |||
| BTA | 9.68 | 0.08 | +0.83% |
| Blackrock Long-Term Municipal Advantage Trust | |||
| VGVT | 75.95 | 0.09 | +0.12% |
| Vanguard Government Securities Actv ETF | |||
| BME | 41.95 | -0.20 | -0.47% |
| Blackrock Health Sciences Trust | |||
| JQUA | 63.66 | -0.77 | -1.20% |
| JPMorgan US Quality Factor ETF | |||
A.I.dvisor tells us that KAJMY and ACA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAJMY and ACA's prices will move in lockstep.
| Ticker / NAME | Correlation To KAJMY | 1D Price Change % | ||
|---|---|---|---|---|
| KAJMY | 100% | N/A | ||
| ACA - KAJMY | 22% Poorly correlated | +1.28% | ||
| KBAGF - KAJMY | 7% Poorly correlated | N/A | ||
| KLRGF - KAJMY | 6% Poorly correlated | +6.18% | ||
| KIERF - KAJMY | 5% Poorly correlated | N/A | ||
| NWSGY - KAJMY | 3% Poorly correlated | N/A | ||
More | ||||